#obesity

This connection may be attributable to lower iron levels.

Nearly a quarter of lean HIV-positive people in a recent study had NAFLD, and 16% of them developed fibrosis.

This finding comes from data on COVID-19 cases diagnosed in people with chronic liver disease and reported to international registries.

This benefit was independent of weight control among the animals.

People with fatty liver disease may have more trouble losing weight

And yet there are no guidelines for screening for the disease in non-obese adolescents.

However, having a higher body mass index might prevent this improvement.

The United States isn’t alone in grappling with this growing health problem.

This finding may help explain why people with the disease struggle to lose weight.

Nonetheless, half of people with NAFLD were able to reach a 5% weight loss goal using a very low energy diet.

This finding from a recent study applies to those who do not have cirrhosis when they are treated for the virus.

And yet there are no guidelines for screening for the disease in non-obese adolescents.

Rising rates of obesity are fueling the epidemic.

Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.

There is perhaps a nine-year lag between increases in obesity and a rise in additions to the NASH-related transplant waiting list.

Rising rates of obesity are fueling the epidemic.